EDGAR Filing Documents for 0001193125-19-235283

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-19-235283

Filing Date

2019-08-30

Accepted

2019-08-30 16:08:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d784764ds3.htm	S-3	520904
2	EX-1.2	d784764dex12.htm	EX-1.2	163096
3	EX-4.6	d784764dex46.htm	EX-4.6	296536
4	EX-4.8	d784764dex48.htm	EX-4.8	97851
5	EX-4.9	d784764dex49.htm	EX-4.9	98755
6	EX-4.10	d784764dex410.htm	EX-4.10	88550
7	EX-5.1	d784764dex51.htm	EX-5.1	28496
8	EX-23.1	d784764dex231.htm	EX-23.1	1927
9	GRAPHIC	g784764dsp177.jpg	GRAPHIC	2667
10	GRAPHIC	g784764g30h52.jpg	GRAPHIC	39235
11	GRAPHIC	g784764g61d79.jpg	GRAPHIC	100487
	Complete submission text file	0001193125-19-235283.txt		1493422

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451

Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400

Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)